Clover Biopharmaceuticals' Series A Round

Clover Biopharmaceuticals raised a round of funding on December 14, 2017. Investors include Tianhe Life Sciences Venture Fund.

Clover Biopharmaceuticals (三叶草生物制药) is a biotechnology company focused on developing novel and transformative biologic therapies.…

Articles about Clover Biopharmaceuticals' Series A Round: